These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 28465104)

  • 1. Phenanthridin-6-one derivatives as the first class of non-steroidal pharmacological chaperones for Niemann-Pick disease type C1 protein.
    Fukuda H; Karaki F; Dodo K; Noguchi-Yachide T; Ishikawa M; Hashimoto Y; Ohgane K
    Bioorg Med Chem Lett; 2017 Jun; 27(12):2781-2787. PubMed ID: 28465104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-activity relationships of oxysterol-derived pharmacological chaperones for Niemann-Pick type C1 protein.
    Ohgane K; Karaki F; Noguchi-Yachide T; Dodo K; Hashimoto Y
    Bioorg Med Chem Lett; 2014 Aug; 24(15):3480-5. PubMed ID: 24928400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of oxysterol-derived pharmacological chaperones for NPC1: implication for the existence of second sterol-binding site.
    Ohgane K; Karaki F; Dodo K; Hashimoto Y
    Chem Biol; 2013 Mar; 20(3):391-402. PubMed ID: 23521797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Niemann-Pick type C1 I1061T mutant encodes a functional protein that is selected for endoplasmic reticulum-associated degradation due to protein misfolding.
    Gelsthorpe ME; Baumann N; Millard E; Gale SE; Langmade SJ; Schaffer JE; Ory DS
    J Biol Chem; 2008 Mar; 283(13):8229-36. PubMed ID: 18216017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Image-based screen capturing misfolding status of Niemann-Pick type C1 identifies potential candidates for chaperone drugs.
    Shioi R; Karaki F; Yoshioka H; Noguchi-Yachide T; Ishikawa M; Dodo K; Hashimoto Y; Sodeoka M; Ohgane K
    PLoS One; 2020; 15(12):e0243746. PubMed ID: 33315900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A murine Niemann-Pick C1 I1061T knock-in model recapitulates the pathological features of the most prevalent human disease allele.
    Praggastis M; Tortelli B; Zhang J; Fujiwara H; Sidhu R; Chacko A; Chen Z; Chung C; Lieberman AP; Sikora J; Davidson C; Walkley SU; Pipalia NH; Maxfield FR; Schaffer JE; Ory DS
    J Neurosci; 2015 May; 35(21):8091-106. PubMed ID: 26019327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone deacetylase inhibitors correct the cholesterol storage defect in most Niemann-Pick C1 mutant cells.
    Pipalia NH; Subramanian K; Mao S; Ralph H; Hutt DM; Scott SM; Balch WE; Maxfield FR
    J Lipid Res; 2017 Apr; 58(4):695-708. PubMed ID: 28193631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative Proteomics of Human Fibroblasts with I1061T Mutation in Niemann-Pick C1 (NPC1) Protein Provides Insights into the Disease Pathogenesis.
    Rauniyar N; Subramanian K; Lavallée-Adam M; Martínez-Bartolomé S; Balch WE; Yates JR
    Mol Cell Proteomics; 2015 Jul; 14(7):1734-49. PubMed ID: 25873482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Niemann-Pick C1 disease: correlations between NPC1 mutations, levels of NPC1 protein, and phenotypes emphasize the functional significance of the putative sterol-sensing domain and of the cysteine-rich luminal loop.
    Millat G; Marçais C; Tomasetto C; Chikh K; Fensom AH; Harzer K; Wenger DA; Ohno K; Vanier MT
    Am J Hum Genet; 2001 Jun; 68(6):1373-85. PubMed ID: 11333381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The proteasome inhibitor bortezomib reduced cholesterol accumulation in fibroblasts from Niemann-Pick type C patients carrying missense mutations.
    Macías-Vidal J; Girós M; Guerrero M; Gascón P; Serratosa J; Bachs O; Coll MJ
    FEBS J; 2014 Oct; 281(19):4450-66. PubMed ID: 25131710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Niemann-Pick type C disease: a QM/MM study of conformational changes in cholesterol in the NPC1(NTD) and NPC2 binding pockets.
    Elghobashi-Meinhardt N
    Biochemistry; 2014 Oct; 53(41):6603-14. PubMed ID: 25251378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coordinate regulation of mutant NPC1 degradation by selective ER autophagy and MARCH6-dependent ERAD.
    Schultz ML; Krus KL; Kaushik S; Dang D; Chopra R; Qi L; Shakkottai VG; Cuervo AM; Lieberman AP
    Nat Commun; 2018 Sep; 9(1):3671. PubMed ID: 30202070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diversity of glycosphingolipid GM2 and cholesterol accumulation in NPC1 patient-specific iPSC-derived neurons.
    Trilck M; Peter F; Zheng C; Frank M; Dobrenis K; Mascher H; Rolfs A; Frech MJ
    Brain Res; 2017 Feb; 1657():52-61. PubMed ID: 27923633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms and consequences of impaired lipid trafficking in Niemann-Pick type C1-deficient mammalian cells.
    Karten B; Peake KB; Vance JE
    Biochim Biophys Acta; 2009 Jul; 1791(7):659-70. PubMed ID: 19416638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of FDA-Approved Drugs as a Therapeutic Approach for Niemann-Pick Disease Type C1 Using Patient-Specific iPSC-Based Model Systems.
    Völkner C; Pantoom S; Liedtke M; Lukas J; Hermann A; Frech MJ
    Cells; 2022 Jan; 11(3):. PubMed ID: 35159129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3.3 Å structure of Niemann-Pick C1 protein reveals insights into the function of the C-terminal luminal domain in cholesterol transport.
    Li X; Lu F; Trinh MN; Schmiege P; Seemann J; Wang J; Blobel G
    Proc Natl Acad Sci U S A; 2017 Aug; 114(34):9116-9121. PubMed ID: 28784760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Niemann-Pick disease type C1(NPC1) is involved in resistance against imatinib in the imatinib-resistant Ph+ acute lymphoblastic leukemia cell line SUP-B15/RI.
    Naren D; Wu J; Gong Y; Yan T; Wang K; Xu W; Yang X; Shi F; Shi R
    Leuk Res; 2016 Mar; 42():59-67. PubMed ID: 26818574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of 58 novel mutations in Niemann-Pick disease type C: correlation with biochemical phenotype and importance of PTC1-like domains in NPC1.
    Park WD; O'Brien JF; Lundquist PA; Kraft DL; Vockley CW; Karnes PS; Patterson MC; Snow K
    Hum Mutat; 2003 Oct; 22(4):313-25. PubMed ID: 12955717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure of human Niemann-Pick C1 protein.
    Li X; Wang J; Coutavas E; Shi H; Hao Q; Blobel G
    Proc Natl Acad Sci U S A; 2016 Jul; 113(29):8212-7. PubMed ID: 27307437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rescue of an in vitro neuron phenotype identified in Niemann-Pick disease, type C1 induced pluripotent stem cell-derived neurons by modulating the WNT pathway and calcium signaling.
    Efthymiou AG; Steiner J; Pavan WJ; Wincovitch S; Larson DM; Porter FD; Rao MS; Malik N
    Stem Cells Transl Med; 2015 Mar; 4(3):230-8. PubMed ID: 25637190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.